| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/25/2001 | CN1064851C Microparticle, manufacture of same and application in diagnosis |
| 04/25/2001 | CN1064847C Seahorse pain-eliminating ointment and its preparing method |
| 04/25/2001 | CN1064846C Gushifu-external application medicine for curing wind-cold syndrome |
| 04/25/2001 | CN1064842C Bagged Chinese medicinal preparation for curing repeated upper respiratory tract infection, and preparing method thereof |
| 04/25/2001 | CN1064839C Compound venin gynostemma pentaphyllum entric solubility capsule |
| 04/24/2001 | US6221979 Crosslinking |
| 04/24/2001 | US6221959 Polynucleotide, polymer complex |
| 04/24/2001 | US6221958 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/24/2001 | US6221919 Utilization of ethoxylated fatty acid esters as self-emulsifiable compounds |
| 04/24/2001 | US6221917 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| 04/24/2001 | US6221915 Pharmaceutical compositions |
| 04/24/2001 | US6221893 Administration of histamine for therapeutic purposes |
| 04/24/2001 | US6221853 Mixture of pharmaceutically acceptable purified paraffinic hydrocarbons, this vehicle having a melting point of about 37 degrees c.+-4 degrees c. |
| 04/24/2001 | US6221852 Pharmaceutical compositions of 5-alkynyl-dideoxyribouracil |
| 04/24/2001 | US6221846 Ophthalmic drug compositions |
| 04/24/2001 | US6221602 Functionalized nanocrystals and their use in labeling for strand synthesis or sequence determination |
| 04/24/2001 | US6221403 Topical composition |
| 04/24/2001 | US6221402 Rapidly releasing and taste-masking pharmaceutical dosage form |
| 04/24/2001 | US6221401 Bilayer structure which encapsulates multiple containment units and uses thereof |
| 04/24/2001 | US6221400 Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors |
| 04/24/2001 | US6221399 Method of making controlled release particles of complexed polymers |
| 04/24/2001 | US6221398 Dissolving an inhalation compound in a solvent; and introducing the solution containing the inhalation compound in droplet form or as a jet stream into an anti-solvent which is miscible with the solvent |
| 04/24/2001 | US6221397 Polymer containing reactive groups selected from the group consisting of carboxyl, hydrazidyl, amino and thiol groups, covalently linked to a dihydrazide spacer |
| 04/24/2001 | US6221396 Oral cisapride dosage forms with an extended duration |
| 04/24/2001 | US6221395 Controlled release pharmaceutical tablets containing an active principle of low water solubility |
| 04/24/2001 | US6221394 In one portion thereof, substantially single (+)-tramadol, and, in another separate portion thereof, substantially single (-)-tramadol; the different tramadol enantiomers are released at different rates from the dosage form. |
| 04/24/2001 | US6221393 Used when it is desired to administer a medicament to a patient over a prolonged period without requiring the patient to take repeat doses at short intervals. |
| 04/24/2001 | US6221392 Rapidly dissolving robust dosage form |
| 04/24/2001 | US6221391 Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith |
| 04/24/2001 | US6221390 Combination pharmaceutical composition and associated methods |
| 04/24/2001 | US6221388 Antibiotic formulation and use for bacterial infections |
| 04/24/2001 | US6221387 Gelified microspheres, their method of preparation and their applications |
| 04/24/2001 | US6221386 Therapeutic agent entrapped within a liposome comprising a smooth lipopolysaccharide from brucella melitensis. |
| 04/24/2001 | US6221385 Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof |
| 04/24/2001 | US6221384 Segmented transdermal dosage unit |
| 04/24/2001 | US6221383 Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| 04/24/2001 | US6221379 Buccal drug administration in female hormone replacement therapy |
| 04/24/2001 | US6221378 Mixed micellar delivery system and method of preparation |
| 04/24/2001 | US6221376 Glial cell line-derived neurotrophic factor |
| 04/24/2001 | US6221370 Fatty acid ethoxylates and partial glycerides for preparing phase inversion temperature emulsions |
| 04/24/2001 | US6221368 As polymeric binder poly(meth)acrylates or their copolymers with (meth)acrylic acid or polyvinylpyrrolidone or copolymers thereof with vinyl esters |
| 04/24/2001 | US6221367 Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex |
| 04/24/2001 | US6221346 Composition with base of coconut oil and its use |
| 04/24/2001 | US6221339 Medicaments |
| 04/24/2001 | US6221338 Method of producing particles for use in dry powder inhalers |
| 04/24/2001 | US6221153 Dissolving compound selected from taxoid or brystatin in solvent; mixing with critical, supercritical or near critical fluid to form solution comprising fluid solvent and compound; precipitating compound as needle like crystal |
| 04/24/2001 | CA2188703C Therapeutic injectable analgesic pharmaceutical composition containing nimesulide 4-nitro, 2-phenoxyphenyl methane sulphonamide for intramuscular administration |
| 04/24/2001 | CA2181390C Phospholipid formulations |
| 04/24/2001 | CA2101164C Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 04/24/2001 | CA2077342C Dispensing device |
| 04/24/2001 | CA2053277C Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 04/24/2001 | CA2041400C Preparation of a medicament |
| 04/24/2001 | CA2032233C Pour-on formulations effective for the control of internal and external parasites of homothermic animals |
| 04/24/2001 | CA2030459C Biodegradable ocular implants |
| 04/24/2001 | CA2027630C Protein gel ophthalmic vehicle |
| 04/19/2001 | WO2001027210A1 Medicament delivery device with moisture resistant coating |
| 04/19/2001 | WO2001027154A2 Membrane translocating peptide drug delivery system |
| 04/19/2001 | WO2001027143A1 Lantibiotic |
| 04/19/2001 | WO2001027140A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | WO2001027123A1 Chromium-histidine complexes as nutrient supplements |
| 04/19/2001 | WO2001027099A2 Bicyclic compounds composition and method for stabilizing the same |
| 04/19/2001 | WO2001026898A1 Device for the production of wet-bonded multi-layer laminates |
| 04/19/2001 | WO2001026728A1 Closed exchange system |
| 04/19/2001 | WO2001026708A1 Reactive polymeric valve, dispensing devices and methods using same |
| 04/19/2001 | WO2001026706A2 Drug delivery catheters that attach to tissue and methods for their use |
| 04/19/2001 | WO2001026705A2 A dual adhesive transdermal drug delivery system |
| 04/19/2001 | WO2001026694A1 Gene therapy for cardiomyopathy |
| 04/19/2001 | WO2001026691A1 Medicinal compositions for oral use |
| 04/19/2001 | WO2001026690A1 Percutaneous permeability-controlling agents and compositions for electroporation containing the same |
| 04/19/2001 | WO2001026689A1 Compositions for electroporation |
| 04/19/2001 | WO2001026688A1 Percutaneous absorption promoters for electroporation |
| 04/19/2001 | WO2001026687A1 Compositions for electroporation |
| 04/19/2001 | WO2001026683A2 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 04/19/2001 | WO2001026663A1 Extended release formulations of erythromycin derivatives |
| 04/19/2001 | WO2001026658A2 Topical nasal treatment using desloratadine |
| 04/19/2001 | WO2001026649A1 Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use |
| 04/19/2001 | WO2001026648A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 04/19/2001 | WO2001026637A2 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid |
| 04/19/2001 | WO2001026636A1 Superficial therapeutic system for topically applying acetylsalicylic acid, for the treatment of acne-related diseases |
| 04/19/2001 | WO2001026635A2 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 04/19/2001 | WO2001026634A1 Tablets with a gellan gum coating |
| 04/19/2001 | WO2001026633A1 Tablets coated with locust bean gum, guar gum or carrageenan gum |
| 04/19/2001 | WO2001026632A1 Compression molded product and production method therefor |
| 04/19/2001 | WO2001026631A1 Surface modified microspheres with cholera toxin b subunit |
| 04/19/2001 | WO2001026630A1 Powdery inhalational preparations and process for producing the same |
| 04/19/2001 | WO2001026629A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | WO2001026628A1 Cationic dosper virosomes |
| 04/19/2001 | WO2001026627A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | WO2001026626A1 Flocculated suspension of megestrol acetate |
| 04/19/2001 | WO2001026625A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | WO2001026622A1 Effervescent tablet for tracing animals being treated, method for producing the same and method for treating an aqueous solution |
| 04/19/2001 | WO2001026621A2 Orally distintegrating composition comprising mirtazapine |
| 04/19/2001 | WO2001026485A1 Method for the production of vitaminized and hydrosoluble vitaminized preparations |
| 04/19/2001 | WO2001003741B1 Growth hormone formulations |
| 04/19/2001 | WO2001003670A8 Method for controlled production of ultrafine microparticles and nanoparticles |
| 04/19/2001 | WO2001002479A8 Pre-formed, self-adhesive sheet devices suitable for topical application |
| 04/19/2001 | WO2001001963A8 A method for the improvement of transport across adaptable semi-permeable barriers |
| 04/19/2001 | WO2000076480A3 Pharmaceutical materials and methods for their preparation and use |
| 04/19/2001 | WO2000066084A8 Aerosol formulations and devices for increasing libido in women via acute testosterone administration |
| 04/19/2001 | WO2000057873A3 Granulate with high content of l-carnitine or an alkanoyl l-carnitine |